Reduced Per2 expression led to decreased immobility in both the TST and FST performed during the test phase (Fig. 4d, e), without significantly affecting locomotion or anxiety-like behavior in the OFT (Supplementary Fig. 4b). The gene discussed is PER2; the disease is Anxiety.